AF.84 BIOIMAGING, BIOCHEMICAL AND GENETIC MARKERS TO STRATIFY PATIENTS WITH METABOLIC ASSOCIATED FATTY LIVER DISEASE (MAFLD) IN CLINICAL PRACTICE: A SINGLE CENTER COHORT STUDY. (September 2021) - Salvati, A.; De Rosa, L.; Faita, F.; Cavallone, D.; Ricco, G.; Colombatto, P.; Coco, B.; Romagnoli, V.; Oliveri, F.; Bonino, F.; Brunetto, M.R.